ETF Holdings Breakdown of NVCR

News associated with NVCR

StockNews.com Downgrades NovoCure (NASDAQ:NVCR) to Sell

NovoCure (NASDAQ:NVCR – Get Free Report) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Wednesday. Other research analysts have also recently issued research reports about the stock. HC Wainwright reissued a “buy” rating and issued a $38.00 target price on shares […] - 2025-04-11 08:18:59

Pictet Asset Management Holding SA Boosts Stake in NovoCure Limited (NASDAQ:NVCR)

Pictet Asset Management Holding SA boosted its holdings in shares of NovoCure Limited (NASDAQ:NVCR – Free Report) by 19.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,919 shares of the medical equipment provider’s stock after acquiring an additional […] - 2025-04-10 08:37:15

21,600 Shares in NovoCure Limited (NASDAQ:NVCR) Purchased by KLP Kapitalforvaltning AS

KLP Kapitalforvaltning AS acquired a new stake in NovoCure Limited (NASDAQ:NVCR – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 21,600 shares of the medical equipment provider’s stock, valued at approximately $644,000. A number of other hedge funds have also modified their holdings of […] - 2025-04-02 08:16:54

NovoCure Limited (NASDAQ:NVCR) Receives $35.80 Consensus PT from Analysts

Shares of NovoCure Limited (NASDAQ:NVCR – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the five brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective […] - 2025-03-24 06:40:48

NovoCure (NASDAQ:NVCR) Raised to “Hold” at StockNews.com

NovoCure (NASDAQ:NVCR – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Tuesday. Other analysts have also issued reports about the stock. Wedbush reissued a “neutral” rating and set a $29.00 target price on shares of NovoCure in a […] - 2025-03-20 05:44:55

Charles Schwab Investment Management Inc. Purchases 11,771 Shares of NovoCure Limited (NASDAQ:NVCR)

Charles Schwab Investment Management Inc. boosted its position in NovoCure Limited (NASDAQ:NVCR – Free Report) by 1.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 836,214 shares of the medical equipment provider’s stock after buying an additional 11,771 shares during the period. […] - 2025-03-19 07:52:57

SBI Securities Co. Ltd. Invests $70,000 in NovoCure Limited (NASDAQ:NVCR)

SBI Securities Co. Ltd. acquired a new position in NovoCure Limited (NASDAQ:NVCR – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund acquired 2,341 shares of the medical equipment provider’s stock, valued at approximately $70,000. Several other institutional investors have also added to or reduced their stakes in the stock. Brooklyn Investment Group bought […] - 2025-03-10 08:07:07

Truist Financial Corp Purchases New Shares in NovoCure Limited (NASDAQ:NVCR)

Truist Financial Corp purchased a new stake in shares of NovoCure Limited (NASDAQ:NVCR – Free Report) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 11,422 shares of the medical equipment provider’s stock, valued at approximately $340,000. A number of other large investors have also added to or reduced their stakes in NVCR. Franklin Resources […] - 2025-03-05 08:40:56

Handelsbanken Fonder AB Has $1.12 Million Position in NovoCure Limited (NASDAQ:NVCR)

Handelsbanken Fonder AB increased its holdings in shares of NovoCure Limited (NASDAQ:NVCR – Free Report) by 9.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 37,523 shares of the medical equipment provider’s stock after buying an additional 3,300 shares during the […] - 2025-02-28 09:24:54

Venturi Wealth Management LLC Sells 1,350 Shares of NovoCure Limited (NASDAQ:NVCR)

Venturi Wealth Management LLC trimmed its position in NovoCure Limited (NASDAQ:NVCR – Free Report) by 36.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,319 shares of the medical equipment provider’s stock after selling 1,350 shares during the period. Venturi Wealth Management […] - 2025-02-25 09:01:02

NVCR institutional holdings

Fatal error: Uncaught mysqli_sql_exception: Column 'Currency_Code' in field list is ambiguous in /var/www/liquidata/show_aggregate_holdings.php:119 Stack trace: #0 /var/www/liquidata/show_aggregate_holdings.php(119): mysqli->query() #1 {main} thrown in /var/www/liquidata/show_aggregate_holdings.php on line 119

Date	ETF ISIN/Name	Num Shares	Book value